315
Views
20
CrossRef citations to date
0
Altmetric
Review

Advances in Aurora kinase inhibitor patents

This review is one of a two part series on Aurora kinase inhibitors. The other part ‘Aurora Kinase Inhibitors in Clinical and Preclinical Testing’ will appear in Expert Opinion in Investigational Drugs.

, , &
Pages 321-356 | Published online: 27 Mar 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Xue-Li Jing & Shi-Wu Chen. (2021) Aurora kinase inhibitors: a patent review (2014-2020). Expert Opinion on Therapeutic Patents 31:7, pages 625-643.
Read now
Marcos Malumbres & Ignacio Pérez de Castro. (2014) Aurora kinase A inhibitors: promising agents in antitumoral therapy. Expert Opinion on Therapeutic Targets 18:12, pages 1377-1393.
Read now
Chun Hei Antonio Cheung, Sailu Sarvagalla, Jane Ying-Chieh Lee, Yi-Chun Huang & Mohane Selvaraj Coumar. (2014) Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 – 2013). Expert Opinion on Therapeutic Patents 24:9, pages 1021-1038.
Read now
Jonathan How & Karen Yee. (2012) ENMD-2076 for hematological malignancies. Expert Opinion on Investigational Drugs 21:5, pages 717-732.
Read now
Chun Hei Antonio Cheung, Mohane Selvaraj Coumar, Jang-Yang Chang & Hsing-Pang Hsieh. (2011) Aurora kinase inhibitor patents and agents in clinical testing: an update (2009 – 10). Expert Opinion on Therapeutic Patents 21:6, pages 857-884.
Read now
Chun Hei Antonio Cheung, Mohane Selvaraj Coumar, Hsing-Pang Hsieh & Jang-Yang Chang. (2009) Aurora kinase inhibitors in preclinical and clinical testing. Expert Opinion on Investigational Drugs 18:4, pages 379-398.
Read now

Articles from other publishers (14)

Azaj Ahmed, Anas Shamsi, Taj Mohammad, Gulam Mustafa Hasan, Asimul Islam & Md. Imtaiyaz Hassan. (2021) Aurora B kinase: a potential drug target for cancer therapy. Journal of Cancer Research and Clinical Oncology 147:8, pages 2187-2198.
Crossref
Tao Yu, Yonglian Zhang, Angela D. Kerekes, Jayaram R. Tagat, Ronald J. Doll, Yushi Xiao, Sara Esposite, Alan Hruza, David B. Belanger, Matthew Voss, Matthew P. Rainka, Andrea Basso, Ming Liu, Lianzhu Liang, Ning Sui, Daniel Prelusky, Diane Rindgen & Likang Zhang. (2018) Discovery of a highly potent orally bioavailable imidazo-[1, 2- a ]pyrazine Aurora inhibitor. Bioorganic & Medicinal Chemistry Letters 28:8, pages 1397-1403.
Crossref
Yi-Yu Ke, Hui-Yi Shiao, Yung Chang Hsu, Chang-Ying Chu, Wen-Chieh Wang, Yen-Chun Lee, Wen-Hsing Lin, Chun-Hwa Chen, John T. A. Hsu, Chun-Wei Chang, Cheng-Wei Lin, Teng-Kuang Yeh, Yu-Sheng Chao, Mohane Selvaraj Coumar & Hsing-Pang Hsieh. (2013) 3D-QSAR-Assisted Drug Design: Identification of a Potent Quinazoline-Based Aurora Kinase Inhibitor. ChemMedChem 8:1, pages 136-148.
Crossref
Matthew E. Voss, Matthew P. Rainka, Mike Fleming, Lisa H. Peterson, David B. Belanger, M. Arshad Siddiqui, Alan Hruza, Johannes Voigt, Kimberly Gray & Andrea D. Basso. (2012) Synthesis and SAR studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off-target kinase selectivity. Bioorganic & Medicinal Chemistry Letters 22:10, pages 3544-3549.
Crossref
Ying Yang, Yulin Shen, Shuyan Li, Nengzhi Jin, Huanxiang Liu & Xiaojun Yao. (2012) Molecular dynamics and free energy studies on Aurora kinase A and its mutant bound with MLN8054: insight into molecular mechanism of subtype selectivity. Molecular BioSystems 8:11, pages 3049.
Crossref
Chun Hei Antonio Cheung, Wen-Hsing Lin, John Tsu-An Hsu, Tzyh-Chyuan Hour, Teng-Kuang Yeh, Shengkai Ko, Tzu-Wen Lien, Mohane Selvaraj Coumar, Jin-Fen Liu, Wen-Yang Lai, Hui-Yi Shiao, Tian-Ren Lee, Hsing-Pang Hsieh & Jang-Yang Chang. (2011) BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells. PLoS ONE 6:8, pages e23485.
Crossref
Chang-Tze Ricky Yu, Jiun-Yi Hsia, Yun-Chih Hseih, Li-Jen Su, Tien-Chiang Lee, Chia-Feng Ku, Ke-Shin Chen, Jou-May Maureen Chen, Tong-You Wade Wei, Yuan-Chii Gladys Lee, Chi-Ying F. Huang, Yu-Chung Wu, Chiou-Ying Yang & Shih-Lan Hsu. (2011) The Novel Protein Suppressed in Lung Cancer Down-Regulated in Lung Cancer Tissues Retards Cell Proliferation and Inhibits the Oncokinase Aurora-A. Journal of Thoracic Oncology 6:6, pages 988-997.
Crossref
Zhaoyang Meng, Bheemashankar A. Kulkarni, Angela D. Kerekes, Amit K. Mandal, Sara J. Esposite, David B. Belanger, Panduranga Adulla Reddy, Andrea D. Basso, Seema Tevar, Kimberly Gray, Jennifer Jones, Elizabeth B. Smith, Ronald J. Doll & M. Arshad Siddiqui. (2011) Bioisosteric approach to the discovery of imidazo[1,2-a]pyrazines as potent Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 21:1, pages 592-598.
Crossref
Joon-Khim Loh, Ann-Shung Lieu, Chia-Hua Chou, Fang-Yi Lin, Chia-Hung Wu, Sheng-Long Howng, Chung-Ching Chio & Yi-Ren Hong. (2010) Differential expression of centrosomal proteins at different stages of human glioma. BMC Cancer 10:1.
Crossref
David B. Belanger, Michael J. Williams, Patrick J. Curran, Amit K. Mandal, Zhaoyang Meng, Matthew P. Rainka, Tao Yu, Neng-Yang Shih, M. Arshad Siddiqui, Ming Liu, Seema Tevar, Suining Lee, Lianzhu Liang, Kimberly Gray, Bohdan Yaremko, Jennifer Jones, Elizabeth B. Smith, Dan B. Prelusky & Andrea D. Basso. (2010) Discovery of orally bioavailable imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 20:22, pages 6739-6743.
Crossref
Payal R. Sheth, Lata Ramanathan, Ashwin Ranchod, Andrea D. Basso, Dianah Barrett, Jia Zhao, Kimberly Gray, Yan-Hui Liu, Rumin Zhang & Hung V. Le. (2010) Expression, purification, stability optimization and characterization of human Aurora B kinase domain from E. coli. Archives of Biochemistry and Biophysics 503:2, pages 191-201.
Crossref
David B. Belanger, Patrick J. Curran, Alan Hruza, Johannes Voigt, Zhaoyang Meng, Amit K. Mandal, M. Arshad Siddiqui, Andrea D. Basso & Kimberly Gray. (2010) Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 20:17, pages 5170-5174.
Crossref
Travis L. Schmit, Mark C. Ledesma & Nihal Ahmad. (2010) Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention. Pharmaceutical Research 27:6, pages 989-998.
Crossref
Mohane Selvaraj Coumar, Ming-Tsung Tsai, Chang-Ying Chu, Biing-Jiun Uang, Wen-Hsing Lin, Chun-Yu Chang, Teng-Yuan Chang, Jiun-Shyang Leou, Chi-Huang Teng, Jian-Sung Wu, Ming-Yu Fang, Chun-Hwa Chen, John T.-A. Hsu, Su-Ying Wu, Yu-Sheng Chao & Hsing-Pang Hsieh. (2010) Identification, SAR Studies, and X-ray Co-crystallographic Analysis of a Novel Furanopyrimidine Aurora Kinase A Inhibitor. ChemMedChem 5:2, pages 255-267.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.